U.S. Markets closed

Keryx Biopharmaceuticals, Inc. (KERX)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
6.46+0.04 (+0.62%)
At close: 4:00PM EDT

6.47 0.01 (0.09%)
After hours: 4:47PM EDT

People also watch
AEZSCLDXARNAACADOREX
Currency in USD

Valuation Measures

Market Cap (intraday) 5700.7M
Enterprise Value 3N/A
Trailing P/E -4.79
Forward P/E 1-28.09
PEG Ratio (5 yr expected) 1-0.08
Price/Sales (ttm)18.95
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6N/A

Financial Highlights

Fiscal Year
Fiscal Year Ends Dec 31, 2016
Most Recent Quarter (mrq)Mar 31, 2017
Profitability
Profit Margin 0.00%
Operating Margin (ttm)-331.22%
Management Effectiveness
Return on Assets (ttm)-42.86%
Return on Equity (ttm)-1,065.48%
Income Statement
Revenue (ttm)36.98M
Revenue Per Share (ttm)0.35
Quarterly Revenue Growth (yoy)73.20%
Gross Profit (ttm)-8.71M
EBITDA -121.5M
Net Income Avi to Common (ttm)-143.15M
Diluted EPS (ttm)-1.35
Quarterly Earnings Growth (yoy)N/A
Balance Sheet
Total Cash (mrq)90.91M
Total Cash Per Share (mrq)0.84
Total Debt (mrq)125M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)5.39
Book Value Per Share (mrq)-0.21
Cash Flow Statement
Operating Cash Flow (ttm)-84.84M
Levered Free Cash Flow (ttm)-80.87M

Trading Information

Stock Price History
Beta 3.49
52-Week Change 39.56%
S&P500 52-Week Change 315.05%
52 Week High 37.80
52 Week Low 34.03
50-Day Moving Average 36.11
200-Day Moving Average 35.75
Share Statistics
Avg Vol (3 month) 31.41M
Avg Vol (10 day) 3975.38k
Shares Outstanding 5108.47M
Float 75.85M
% Held by Insiders 126.59%
% Held by Institutions 161.50%
Shares Short 322.05M
Short Ratio 315.92
Short % of Float 327.43%
Shares Short (prior month) 322.21M
Dividends & Splits
Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 4N/A
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A